Advertisement

Topics

NA | DRITHO-CREME [Summers Laboratories Inc] | BioPortfolio

13:43 EST 27th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

COMPOSITION: CREAM CONTAINING ANTHRALIN U.S.P. 1.0%

A BASE OF WHITE PETROLATUM, SODIUM LAURYL SULFATE, CETOSTEARYL ALCOHOL, ASCORBIC ACID, SALICYLIC ACID, METHYLPARABEN AND PURIFIED WATER.

INDICATION

AN AID IN THE TOPICAL TREATMENT OF QUIESCENT OR CHRONIC PSORIASIS.

WARNING

FOR EXTERNAL USE ONLY.

AN AID IN THE TOPICAL TREATMENT OF PSORIASIS.

KEEP OUT OF THE REACH OF CHILDREN.

Manufacturer

Summers Laboratories Inc

Active Ingredients

Source

Clinical Trials [17 Associated Clinical Trials listed on BioPortfolio]

A Comparative Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Pediculosis Capitis

A comparative safety and efficacy study of NatrOVA Creme Rinse - 1% versus NIX Creme Rinse, under actual use conditions in subjects 6 months of age or greater who are infested with Pedicul...

Safety and Efficacy Study of NatrOVA - 1% Creme Rinse and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice

A comparative safety and efficacy study of NatrOVA Creme Rinse - 1% versus NIX Creme Rinse, under actual use conditions in subjects 6 months of age or greater who are infested with Pedicul...

A Safety and Efficacy Pilot Study Comparing NatrOVA Creme Rinse 1% and NIX Creme Rinse

A pilot study to compare the safety and efficacy of NatrOVA Creme Rinse 1% to NIX Creme Rinse in subjects with Pediculosis Capitis

A Pharmacokinetic (PK) Study of NatrOVA Topical Creme (1%) in Pediatric Subjects 6 to 24 Months of Age

This is an open label, single center, single dose PK study of NatrOVA Creme Rinse (1%), an investigational treatment for head lice and nits, in normal, healthy infants.

Phototoxicity Potential of NatrOVA Creme Rinse - 1%

This study will evaluate the primary irritation potential of NatrOVA Creme Rinse - 1% in humans, after exposure to UV radiation.

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Core-multishell nanocarriers enhance drug penetration and reach keratinocytes and antigen-presenting cells in intact human skin.

In reconstructed skin and diffusion cell studies, core-multishell nanocarriers (CMS-NC) showed great potential for drug delivery across the skin barrier. Herein, we investigated penetration, release o...

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Alzumab (Itolizumab)
Biocon Launches ALZUMAb™ - a ‘First in Class’ Novel Biologic Treatment for Psoriasis Patients in India • ALZUMAb™-World's first novel anti-CD6 antibody developed by Biocon to address a large unmet need for th...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record